Diagnostics technology pioneer Oxford Immunotec partners with IFS to drive future growth
Comprehensive ERP solution from IFS to unify business processes and empower staff across three continents
London, May 5, 2020 – IFS, the global enterprise applications company, announces that Oxford Immunotec, a global, high-growth diagnostics company focused on developing and commercializing proprietary assays for immunology and infectious disease, has chosen to implement IFS Applications™ as its central enterprise resource planning (ERP) system across its global organization.
To support its future growth, Oxford Immunotec was looking for a fully integrated ERP solution that could replace and unify its disparate business systems while supporting its ability to stay compliant with regulatory requirements, as well as controlling quality and traceability according to industry standards.
Following a competitive bid process, IFS stood out as the vendor best capable of delivering a complete industry solution.
“IFS presented a very convincing business value proposition, which was backed by a number of solid customer references in the diagnostics industry,” Oxford Immunotec’s Vice President of Information Technology, Bernie Kalmbach said. “We are excited to have found a technology partner interested in building value in the long term.”
Alan Laing, Managing Director, IFS UK and Ireland, added, “We are immensely proud to partner with Oxford Immunotec, whose people are on the frontline in the crucial field of diagnostics. Our solutions for the quality-centric, stringently regulated life sciences industry are built to offer support across the entire business and we look forward to working with Oxford Immunotec to ensure they stay compliant and efficient in the weeks, months, and years to come.”
Learn more about how IFS supports businesses in the life sciences at www.ifs.com/corp/industries/manufacturing/life-sciences/.
Christine Murphy, Marketing Director, IFS UK & Ireland. Phone: 44 (0)7764 565576, press@ifs.com
About Oxford Immunotec
Oxford Immunotec Global PLC is a global, high-growth diagnostics company focused on developing and commercializing proprietary assays for immunology and infectious disease. The Company’s T-SPOT.TB test has been approved for sale in over 60 countries, including the United States, where it has received pre-market approval from the Food and Drug Administration, Europe, where it has obtained a CE mark, as well as Japan and China. The Company is headquartered near Oxford, U.K. and in Marlborough, MA. Additional information can be found at www.oxfordimmunotec.com.
T-SPOT and the Oxford Immunotec logo are trademarks of Oxford Immunotec Ltd.
About IFS
IFS develops and delivers enterprise software for customers around the world who manufacture and distribute goods, build and maintain assets, and manage service-focused operations. The industry expertise of our people and solutions, together with a commitment to delivering value to every one of our customers, has made IFS a recognized leader and the most recommended supplier in our sector. Our team of 4,000 employees and growing ecosystem of partners support more than 10,000 customers around the world challenge the status quo and realize their competitive advantage. Learn more about how our enterprise software solutions can help your business today at ifs.com.
Follow us on Twitter: @ifs
Visit the IFS Blog on technology, innovation and creativity: https://blog.ifs.com/
